New HIV Treatment Option Greenlit
The FDA expanded approval of ViiV Healthcare's Dovato, making it available to HIV-positive people not new to treatment.
August 07 2020 7:43 PM
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The FDA expanded approval of ViiV Healthcare's Dovato, making it available to HIV-positive people not new to treatment.
A single tablet containing the drugs dolutegravir and lamivudine continues to show long-term efficacy.
The two Merck drugs showed promising results after the DRIVE-SHIFT trial.
A simple move from one class of inhibitor to another could decrease your risk of developing life-threatening diseases.
Activist Jim Chud lived with HIV for decades. Before his death, he open up with Plus about the AIDS crisis, future of HIV, and what he's learned.
Our most up-to-date and comprehensive look at the medications approved by the Food And Drug Administration for the treatment of HIV and related conditions.
Plus offers a comprehensive look at the medications approved by the Food and Drug Administration for the treatment of HIV and opportunistic infections as well as a state-by-state map of drug assistance programs plus info on complementary therapies and drug trials, all in a downloadable form.
The company anticipates rolling out the new medication in 2017.
New, long acting-injectable HIV meds offer hope for those with multi-drug resistant strains of the disease.
Everything you need to know about antiretroviral resistance, how it happens, and how to combat it.
A monthly injectable treatment could change what it means to be HIV-positive.
This long-term survivor was the last person you'd imagine going off treatment — but he did. Here's what happened next.
When it comes to your HIV treatment, not all pills are created equally.
I’ve been on the same HIV medications for nearly a decade. Is it time to switch?
I’m finally admitting I’m the reason my meds aren’t working.